Abstract

Progression of eukaryotic cells through the cell cycle is governed by the sequential formation, activation, and subsequent inactivation of a series of cyclin-dependent kinase (Cdk) complexes. p27(Kip1) (p27) is a Cdk inhibitor that blocks, in vitro, the activity of cyclin D-Cdk4, cyclin D-Cdk6, cyclin E-Cdk2 as well as cyclin A-Cdk2, a complex active during S phase. The level of p27 protein expression, usually high in G0/G1 resting cells, declines as cells progress toward S phase and enforced expression of p27 in fibroblasts causes G1 arrest. This situation prevails in CCL39, a Chinese hamster lung fibroblast cell line (this report). However, in addition to p27, several other Cdk inhibitors known to alter G1 progression coexist in most mammalian cells. To investigate the specific contribution of p27 in the control of the mitogen-sensitive G0/G1 arrest, we specifically reduced its synthesis by expressing a full-length p27 antisense cDNA in CCL39 cells. Interestingly, reduction of up to 90% of p27 protein expression increased both basal and serum-stimulated gene transcription of cyclin D1, cyclin A, dihydrofolate reductase, and DNA synthesis reinitiation. Moreover, overexpression of this antisense allows cells to grow for several generations in a serum-free medium supplemented with insulin and transferrin only, thus suggesting that p27-depleted cells cannot exit the cell cycle. These effects were fully reversed by coexpression of a plasmid encoding p27 sense. We conclude that p27, by setting the level of growth factor requirement, plays a pivotal role in controlling cell cycle exit, a fundamental step in growth control.

Highlights

  • Cell cycle progression is controlled by cyclin-dependent kinases (Cdks)1 counterbalanced by Cdk inhibitors (CKIs) [1]

  • Immune complexes prepared with antisera to cyclin D1 or Cdk4 lacked kinase activity able to phosphorylate the retinoblastoma protein

  • It has been proposed that this Cdk inactivation results from an excess of p21 and p27 titrating out cyclin-Cdk complexes [1, 13, 17, 25, 27, 28]

Read more

Summary

Introduction

Cell cycle progression is controlled by cyclin-dependent kinases (Cdks)1 counterbalanced by Cdk inhibitors (CKIs) [1]. 1 The abbreviations used are: Cdk, cyclin-dependent kinase; CKI, Cdk inhibitor; MAP, mitogen-activated protein kinase; DMEM, Dulbecco’s modified Eagle’s medium; FCS, fetal calf serum.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call